Literature DB >> 28597413

Late-onset ornithine transcarbamylase deficiency associated with hyperammonemia.

Kana Daijo1, Tomokazu Kawaoka2, Takashi Nakahara1, Yuko Nagaoki1, Masataka Tsuge1, Akira Hiramatsu1, Michio Imamura1, Yoshiiku Kawakami1, Hiroshi Aikata1, Keiichi Hara3, Go Tajima4, Masao Kobayashi4, Kazuaki Chayama1.   

Abstract

The urea cycle converts ammonia and produces urea. One form of urea cycle abnormality is ornithine transcarbamylase (OTC) deficiency. This hereditary disorder is associated with hyperammonemia. OTC deficiency commonly appears during neonatal and early childhood life and is rare in adults. We report a 69-year-old man who presented at the local hospital with 3-day loss of appetite, early morning vomiting, and state of confusion. Blood ammonia was 293 μg/dl. At 2-3 h after admission, the patient went into a deep coma. He was intubated and admitted immediately to the intensive care unit. Treatment, including sustained hemodialysis, failed to lower blood ammonia level. His grandchild died of OTC deficiency at 6 year of age. Computed tomography, magnetic resonance imaging and esophagogastroduodenoscopy showed no abnormalities. On admission to our hospital, he complained of vomiting and disturbance of consciousness, hyperammonemia, and normal anion gap. Genetic analysis showed A208T mutation. The deceased grandchild with OTC deficiency also had the same mutation. Long-term hemodialysis coupled with administration of L-arginine and lactulose resulted in improvement of blood ammonia level. Early diagnosis and treatment of adult-onset OTC deficiency are essential to avoid serious complications.

Entities:  

Keywords:  A208T; Late-onset; OTC

Mesh:

Year:  2017        PMID: 28597413     DOI: 10.1007/s12328-017-0753-0

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  9 in total

1.  Long-term outcome and intervention of urea cycle disorders in Japan.

Authors:  Jun Kido; Kimitoshi Nakamura; Hiroshi Mitsubuchi; Toshihiro Ohura; Masaki Takayanagi; Masafumi Matsuo; Makoto Yoshino; Yosuke Shigematsu; Tohru Yorifuji; Mureo Kasahara; Reiko Horikawa; Fumio Endo
Journal:  J Inherit Metab Dis       Date:  2011-12-14       Impact factor: 4.982

2.  Y55D mutation in ornithine transcarbamylase associated with late-onset hyperammonemia in a male.

Authors:  A Nishiyori; M Yoshino; Y Tananari; T Matsuura; R Hoshide; I Mastuda; M Mori; H Kato
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

3.  Long-term treatment of girls with ornithine transcarbamylase deficiency.

Authors:  N E Maestri; S W Brusilow; D B Clissold; S S Bassett
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

4.  Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene.

Authors:  Saori Yamaguchi; Lisa L Brailey; Hiroki Morizono; Allen E Bale; Mendel Tuchman
Journal:  Hum Mutat       Date:  2006-07       Impact factor: 4.878

5.  Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.

Authors:  I Matsuda; T Matsuura; A Nishiyori; S Komaki; R Hoshide; T Matsumoto; M Funakoshi; K Kiwaki; F Endo; A Hata; M Shimadzu; M Yoshino
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

6.  Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family.

Authors:  M G Ausems; E Bakker; R Berger; M Duran; O P van Diggelen; J L Keulemans; H W de Valk; A L Kneppers; L Dorland; P F Eskes; F A Beemer; B T Poll-The; J A Smeitink
Journal:  Am J Med Genet       Date:  1997-01-20

Review 7.  Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.

Authors:  Daisuke Morioka; Mureo Kasahara; Yasutsugu Takada; Yasumasa Shirouzu; Kaoru Taira; Seisuke Sakamoto; Kenji Uryuhara; Hiroto Egawa; Hiroshi Shimada; Koichi Tanaka
Journal:  Liver Transpl       Date:  2005-11       Impact factor: 5.799

8.  Acute fatal presentation of ornithine transcarbamylase deficiency in a previously healthy male.

Authors:  Ophir D Klein; Dana R Kostiner; Kara Weisiger; Ellen Moffatt; Neal Lindeman; Stephen Goodman; Mendel Tuchman; Seymour Packman
Journal:  Hepatol Int       Date:  2008-05-07       Impact factor: 6.047

9.  Fatal hyperammonaemia due to late-onset ornithine transcarbamylase deficiency.

Authors:  G P Bijvoet; C J M van der Sijs-Bos; J P M Wielders; O A Groot
Journal:  Neth J Med       Date:  2016-01       Impact factor: 1.422

  9 in total
  6 in total

Review 1.  Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism.

Authors:  Michel Tchan
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

Review 2.  Fifteen years of urea cycle disorders brain research: Looking back, looking forward.

Authors:  Kuntal Sen; Matthew Whitehead; Carlos Castillo Pinto; Ljubica Caldovic; Andrea Gropman
Journal:  Anal Biochem       Date:  2021-10-09       Impact factor: 3.365

Review 3.  Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue.

Authors:  Kuntal Sen; Afrouz A Anderson; Matthew T Whitehead; Andrea L Gropman
Journal:  Front Neurol       Date:  2021-04-28       Impact factor: 4.086

4.  Investigation of Liver Injury of Polygonum multiflorum Thunb. in Rats by Metabolomics and Traditional Approaches.

Authors:  Yun-Xia Li; Xiao-Hong Gong; Mei-Chen Liu; Cheng Peng; Peng Li; Yi-Tao Wang
Journal:  Front Pharmacol       Date:  2017-11-01       Impact factor: 5.810

5.  Ammonia and coma - a case report of late onset hemizygous ornithine carbamyltransferase deficiency in 68-year-old female.

Authors:  Justus Marquetand; Peter Freisinger; Tobias Lindig; Sebastian Euler; Michael Gasser; Dietrich Overkamp
Journal:  BMC Neurol       Date:  2020-04-06       Impact factor: 2.474

Review 6.  Management of late onset urea cycle disorders-a remaining challenge for the intensivist?

Authors:  S Redant; A Empain; A Mugisha; P Kamgang; R Attou; P M Honoré; D De Bels
Journal:  Ann Intensive Care       Date:  2021-01-06       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.